PET/CT powers MPI improvements

May 29, 2013

There are several advantages to PET/CT for myocardial perfusion imaging (MPI) including upgrades in quantitative analysis and biomarker technology that could provide a more complete evaluation of cardiovascular disease, according to a review published in the Journal of Nuclear Cardiology.

Amit Pursnani, MD, from Massachusetts General Hospital and Harvard Medical School in Boston, and colleagues explored the value of PET/CT in applications of MPI. In contrast with conventional SPECT imaging, PET/CT MPI is associated with a lower radiation dose and provides opportunities for quantitative analysis, including calculations of absolute coronary flow reserve (CFR) and myocardial blood flow (MBF) made possible with developments using rubidium-82.